Seychelles vs Tonga: The number of people with susceptibility test result for rifampicin
Seychelles
9
in 2021
Tonga
7
in 2021
Seychelles rank
140th
Tonga rank
141st
The number of people with susceptibility test result for rifampicin over time
- Seychelles
- Tonga
How they compare
Seychelles currently reports 9 against 7 in Tonga, a difference of 2.
That makes Seychelles's figure about 1.3 times Tonga's.
Across all 5 years both countries report, Seychelles has been ahead every year.
Seychelles ranks 140th and Tonga ranks 141st of 155 countries.
Seychelles has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Seychelles | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 12.67 | 6 | 6.67 | Seychelles |
| 2020s | 8 | 6 | 2 | Seychelles |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Seychelles or Tonga?
- Seychelles, at 9 against 7 in Tonga as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Seychelles and Tonga?
- 2, with Seychelles ahead.
- How many years of comparable data are there for Seychelles and Tonga?
- 5 years are reported by both, from 2017 to 2021.
- How do Seychelles and Tonga rank globally for the number of people with susceptibility test result for rifampicin?
- Seychelles ranks 140th and Tonga ranks 141st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.